The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mason Michael since 2012.
This trader's CIK number is 1514291.
At the time of last reporting, Mason Michael was the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc.. (stock ticker symbol KPTI).
Also see all insider trading activities at Karyopharm Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | KPTI | 0 | $0 | 48,301 | $55,564 | 0 | $0 |
| 2023 | KPTI | 0 | $0 | 25,692 | $67,128 | 0 | $0 |
| 2022 | KPTI | 0 | $0 | 6,946 | $67,113 | 0 | $0 |
| 2021 | KPTI | 0 | $0 | 2,858 | $44,353 | 8,150 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ALNY | 0 | $0 | 36,745 | $4,872,460 | 40,283 | $2,559,323 |
| 2017 | ALNY | 0 | $0 | 9,375 | $656,250 | 9,375 | $120,750 |
| 2015 | ALNY | 0 | $0 | 4,791 | $631,884 | 4,791 | $239,526 |
| 2014 | ALNY | 0 | $0 | 25,912 | $2,499,533 | 20,625 | $236,568 |
| 2013 | ALNY | 0 | $0 | 76,575 | $2,996,936 | 76,575 | $1,453,000 |
| 2012 | ALNY | 0 | $0 | 25,295 | $471,429 | 25,295 | $265,483 |
1. Karyopharm Therapeutics Inc. (KPTI)
2. Alnylam Pharmaceuticals, Inc. (ALNY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-04 | KPTI | Sale | 7,050 | .72 | 5,090 |
| 2024-06-04 | KPTI | Sale | 652 | .99 | 645 |
| 2024-03-01 | KPTI | Sale | 6,162 | 1.20 | 7,394 |
| 2024-02-29 | KPTI | Sale | 27,687 | 1.17 | 32,393 |
| 2024-02-27 | KPTI | Sale | 2,545 | 1.32 | 3,369 |
| 2024-02-06 | KPTI | Sale | 4,205 | 1.59 | 6,673 |
| 2023-09-01 | KPTI | Sale | 6,913 | 1.33 | 9,201 |
| 2023-06-02 | KPTI | Sale | 631 | 2.22 | 1,400 |
| 2023-03-01 | KPTI | Sale | 11,205 | 3.03 | 33,939 |
| 2023-02-27 | KPTI | Sale | 2,802 | 3.04 | 8,509 |
| 2023-02-06 | KPTI | Sale | 4,141 | 3.40 | 14,079 |
| 2022-06-03 | KPTI | Sale | 601 | 6.05 | 3,638 |
| 2022-02-28 | KPTI | Sale | 2,398 | 10.24 | 24,550 |
| 2022-02-07 | KPTI | Sale | 3,947 | 9.86 | 38,925 |
| 2021-02-11 | KPTI | Sale | 2,858 | 15.52 | 44,353 |
| 2021-02-05 | KPTI | Option Ex | 8,150 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-04 | ALNY | Sale | 36,745 | 132.60 | 4,872,460 |
| 2018-01-04 | ALNY | Option Ex | 31,781 | 80.53 | 2,559,323 |
| 2017-12-30 | ALKS | Option Ex | 8,502 | .00 | 0 |
| 2017-05-16 | ALNY | Option Ex | 9,375 | 12.88 | 120,750 |
| 2017-05-16 | ALNY | Sale | 9,375 | 70.00 | 656,250 |
| 2015-06-01 | ALNY | Sale | 4,791 | 131.89 | 631,884 |
| 2015-06-01 | ALNY | Option Ex | 4,791 | 49.99 | 239,526 |
| 2014-12-15 | ALNY | Option Ex | 20,625 | 11.47 | 236,568 |
| 2014-12-15 | ALNY | Sale | 22,162 | 99.42 | 2,203,456 |
| 2014-02-03 | ALNY | Sale | 3,750 | 78.95 | 296,077 |
| 2013-12-16 | ALNY | Sale | 8,000 | 60.49 | 483,888 |
| 2013-12-16 | ALNY | Option Ex | 8,000 | 12.18 | 97,464 |
| 2013-12-02 | ALNY | Option Ex | 3,750 | 7.10 | 26,625 |
| 2013-12-02 | ALNY | Sale | 3,750 | 61.84 | 231,881 |
| 2013-07-12 | ALNY | Sale | 14,200 | 50.00 | 710,000 |
| 2013-07-12 | ALNY | Option Ex | 14,200 | 31.39 | 445,738 |
| 2013-07-01 | ALNY | Option Ex | 27,000 | 22.05 | 595,350 |
| 2013-07-01 | ALNY | Sale | 27,000 | 32.00 | 864,000 |
| 2013-06-17 | ALNY | Option Ex | 23,625 | 12.18 | 287,823 |
| 2013-06-17 | ALNY | Sale | 23,625 | 29.93 | 707,167 |
| 2012-11-30 | ALNY | Sale | 3,750 | 16.93 | 63,472 |
| 2012-11-30 | ALNY | Option Ex | 3,750 | 7.10 | 26,625 |
| 2012-07-27 | ALNY | Option Ex | 6,250 | 10.98 | 68,625 |
| 2012-07-27 | ALNY | Sale | 6,250 | 20.00 | 125,000 |
| 2012-07-16 | ALNY | Option Ex | 15,295 | 11.13 | 170,233 |
| 2012-07-16 | ALNY | Sale | 15,295 | 18.50 | 282,957 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mason Michael (EVP, CFO & Treasurer of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.